Literature DB >> 29793416

Oleanolic Acid Ameliorates Aβ25-35 Injection-induced Memory Deficit in Alzheimer's Disease Model Rats by Maintaining Synaptic Plasticity.

Kai Wang1, Weiming Sun1, Linlin Zhang2, Wei Guo2, Jiachun Xu1, Shuang Liu2, Zhen Zhou2, Yulian Zhang2.   

Abstract

BACKGROUND: Abnormal amyloid β (Aβ) accumulation and deposition in the hippocampus is an essential process in Alzheimer's disease (AD).
OBJECTIVE: To investigate whether Oleanolic acid (OA) could improve memory deficit in AD model and its possible mechanism.
METHODS: Forty-five SD rats were randomly divided into sham operation group, model group, and OA group. AD models by injection of Aβ25-35 were built. Morris water maze (MWM) was applied to investigate learning and memory, transmission electron microscope (TEM) to observe the ultrastructure of synapse, western blot to the proteins, electrophysiology for long-term potentiation (LTP), and Ca2+ concentration in synapse was also measured.
RESULTS: The latency time in model group was significantly longer than that in sham operation group (P=0.0001); while it was significantly shorter in the OA group than that in model group (P=0.0001); compared with model group, the times of cross-platform in OA group significantly increased (P=0.0001). TEM results showed OA could alleviate neuron damage and synapses changes induced by Aβ25-35. The expressions of CaMKII, PKC, NMDAR2B, BDNF, TrkB, and CREB protein were significantly improved by OA (P=0.0001, 0.036, 0.041, 0.0001, 0.0001, 0.026, respectively) compared with that in model group; the concentration of Ca2+ was significantly lower in OA group (1.11±0.42) than that in model group (1.68±0.18); and the slope rate (P=0.0001) and amplitude (P=0.0001) of f- EPSP significantly increased in OA group.
CONCLUSION: The present results support that OA could ameliorate Aβ-induced memory loss of AD rats by maintaining synaptic plasticity of the hippocampus. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Alzheimer's disease; Aβ; Ca2+; Oleanolic acid; long-term potentiation; synaptic plasticity.

Mesh:

Substances:

Year:  2018        PMID: 29793416      PMCID: PMC6327117          DOI: 10.2174/1871527317666180525113109

Source DB:  PubMed          Journal:  CNS Neurol Disord Drug Targets        ISSN: 1871-5273            Impact factor:   4.388


Introduction

Alzheimer’s disease (AD) is characterized by progressive memory loss, and the amyloid β (Aβ) peptide with its accumulation, due to overproduction and/or the failure of clearance mechanisms, followed by neuronal death, has been the upstream cause of AD over the past decades [1-3]. Abnormal Aβ accumulation and deposition in the hippocampus, the first regions of the brain to suffer damage which plays important roles in the consolidation of short-term memory, long-term memory, and spatial memory [4], is an essential process in the pathological events occurring in individuals with AD [5, 6]. Multiple studies reported that dysregulation of neuronal Ca2+ homeostasis also plays a pivotal role in AD pathogenesis [7, 8]. Aβ-mediated toxicity could regulate the calcium channels in the membrane to promote extracellular Ca2+ influx [9], and/or release intracellular Ca2+ pool [10, 11], to constantly enhance intracellular Ca2+ concentration, leading to calcium overload, which could increase the neuronal sensitivity to excitotoxicity and apoptosis [12], eventually leading to neuronal synaptic injury, resulting in learning and memory impairment. Therefore, it could improve learning and memory ability in AD patients by reducing Aβ-mediated toxicity and intracellular Ca2+ concentration. The complicated and still unclear pathogenesis of AD made it hard to treat it. Though there are a few medications currently being used, no one has been clearly shown to delay or halt the progression of AD [13], even with many reported adverse effects [14-16], which drives researchers to look for new treatments to alter the course of AD. Nowadays, natural products and their extracts are promising drug candidates [17-19], and many of them, such as Huperzine A [20], Galantamine [21], and (-)-Epigallocatechin-3-gallate [22, 23], have shown an effect in treating AD. Similarly, many extracts from several traditional Chinese herbs such as Astragalus membranaceus [24], Paeonia suffruticosa [25], Magnolia ofcinalis [26], and Rhizoma anemarrhenae [27] have been reported to effectively prevent memory impairment. Oleanolic acid (OA), a natural extract from the traditional Chinese herb Ligustrum lucidum (Nv Zhenzi), was found to exhibit weak anti-HIV [28], anti-HCV [29], anti-inflammatory [30, 31], and anti-cancer [32, 33] properties. Combined with other herbs, Ligustrum lucidum could delay memory loss of AD in our previous clinical study [34], and further study is still needed to investigate the mechanism of OA against the AD. Therefore, in this study, we build AD model rats by right intracerebroventricular injection of Aβ25-35, after intervened by OA for four weeks, to investigate whether OA could improve learning and memory deficit and its possible mechanism.

Material and Methods

Animals

Eight-week-male Sprague-Dawley rats (230-250g, from Beijing Vital River Laboratory Animal Technology Co., Ltd, Beijing, China) were kept at a 12h light/dark cycle under controlled temperature (22±2°C) and humidity (50±10%), and bred with standard diet and water ad libitum, acclimatized for 7 days before the experiments. All animal procedures were approved by the local ethical committee at Tianjin University of Traditional Chinese Medicine and met the guidelines of the Guide for the Care and Use of Laboratory Animals published by the National Institutes of Health (Documentation 55, 2001).

Drugs and Reagents

Oleanolic acid (purity>98%, Melonepharma), 2mg/mL, was suspended in 5% sodium carboxymethyl cellulose, and amyloid β-Protein Fragment 25-35 (Aβ25-35, purity≥97%, Sigma) was dissolved in 0.9% sterile water at a concentration of 4μg/μL and incubated at 37°C for 96h to induce aggregation before usage. The selection of OA dose in rats was calculated by equivalent dose ratio [Rat(200g):Human(70kg)=6.3], based on the clinical application of OA in patients (240mg/d/70kg), the result was 21.6mg/kg for a rat. The concentration of OA for AD rats was 2mg/mL, thus we selected the dose of 10mL/kg.

Modeling and Administration

Forty-five SD rats were randomly divided into three groups: the sham operation group, the model group, and the OA group, 15 in each group. Rats were anaesthetized by intraperitoneal injection of 10% chloral hydrate (0.3g/kg) and fixed in the rat brain stereotaxic device (Ruiwode Life Technology Co., Ltd, China). A hole was drilled on the right parietal bone (anteroposteriorly [AP], 1mm; laterally right [LR], 1.5mm; and dorsoventrally [DV], 4mm) [35]. The rats in the sham operation group received a right intracerebroventricular injection of 0.9% sterile saline 5μL (speed, 1μL/min), while the rats in the model and OA group received a right intracerebroventricular injection of Aβ25-35 solution 5μL [36] at the same speed. The rats in OA group received OA treatments intragastricly administrated (10mL/kg) seven days after Aβ25-35 infusion, once daily from then on before water maza test, for four weeks, while distilled water was administrated (10mL/kg) to rats in other groups.

Morris Water Maze (MWM) Test

Spatial learning ability was tested using the Morris water maze (MWM) test after four-week intragastric administration. The water maze was an open circular black tank (120cm in diameter and 60 cm in height) and a movable circular platform (8cm in diameter). A camera two meters above the tank was connected to the computer to record the rat’s movement, and the data was analyzed by TopScanLite (CleverSys Inc). The tank was filled with water at a height of 23cm (23-25°C) and dyed with black edible pigment [37]. The tank was divided into 4 quadrants by two imaginary perpendicular axes with four cardinal points: North (N), South (S), East (E) and West (W), and the platform was placed in the middle of SW quadrant, 2cm submerged into the water surface. MWM test was started with the place navigation trial, and each rat in all groups (n=15 in each group) underwent four trials per day with a one-minute-interval for 5 consecutive days. The rat was gently placed in the water from the starting position (location of SE, NE, SW, and NW quadrant, respectively), facing the wall of the tank. The rat was allowed to swim for 90 seconds until it found the submerged platform and stayed on the platform for a maximum of 10 seconds. If the rat failed to find the hidden platform within 90 seconds, it would be guided to the platform and remained on the platform for a maximum of 10 seconds before being removed from the pool. The escape latency was defined as the time taken to search for the platform within 90 seconds. The escape latency, swimming speed, and swimming path were recorded by the tracking system. The spatial probe test was conducted 24 hours after the 5-day place navigation trial where the platform was removed from the pool to assess memory retention for the location of the platform. The rat was put into the pool at the NE point and allowed to swim for 90 seconds. The swimming speed, swimming path, and the frequency of rat crossing the virtual platform were recorded.

Transmission Electron Microscope

Rats (n=3 in each group) were anesthetized by intraperitoneal injection 10% chloral hydrate (0.3g/kg) after MWM test. The brain was removed rapidly and placed on ice. The CA1 region of the left hippocampus was dissected and then diced into smaller blocks of 1mm×1mm×1mm. The methods to prepare samples were as follows: the specimens were fixed by immersing in 4% buffered glutaraldehyde 4 h, and then washed in cold 1/15M phosphate buffered saline 15-30min for 3 times. The tissues were then post-fixed for 2 h in 1% osmium tetroxide, and washed in cold 1/15M phosphate buffered saline 30min for 3 times. The samples were dehydrated in ascending grades of acetone: 50%, 70%, 80%, 90%, 15 min respectively, and then in 100% acetone 15min ×2. The tissues were infiltrated in embedding medium for 3 h at room temperature, 60 min in mixture of 100% acetone/embedding medium (1:1) in 37oC, overnight in mixture of 100% acetone/embedding medium (1:3) in 37oC, 5 h in embedding medium in 37oC. All tissues were embedded and then cured in a 37oC oven for 24 h followed by 48 h in a 60oC oven. The samples were sliced into 50nm with an ultra-microtome (Leica UCT, Germany). The samples were stained with uranyl acetate for 45 min, and then stained with lead citrate for 15 min. A transmission electron microscope (TEM) (Hitachi H7500, Japan) was used to observe the neurons using.

Western Blot Analysis

Rats (n=5 in each group) were sacrificed for extracting protein samples from right hippocampi after MWM test by splitting, centrifugation, and boiling. Equal amounts (40 μg) of protein were loaded into each well of a sodium dodecyl sulfate-polyacrylamide gel (10% polyacrylamide gels) and separated by electrophoresis. The proteins were then transferred to nitrocellulose membranes (Amersham, USA), which were blocked with 5% bovine serum albumin and prepared in a Tris-buffered saline (TBS) overnight at 4°C. The membranes were incubated with antibodies to detect CaMKII (ab134041, 1:1000), PKC (ab136491, 1:1000), NMDAR2B (ab65783, 1:1000), BDNF (ab205067, 1:1000), TrkB (sc-377218, 1:1000), CREB (ab32515, 1:1000), GAPDH (ab8245, 1:1000) and beta Actin (ab184220 1:1000), followed by incubation with appropriate HRP-conjugated goat anti-rabbit (ZSGB-BIO, China; ZB-5301, 1:1,000) or HRP-conjugated goat anti-mouse secondary antibodies (ZSGB-BIO, China; ZB-5305, 1:1,000). Immunoreactive bands were visualized using the BeyoECL Plus (Beyotime Company, China), and the resulting membranes were imaged using the VersaDoc MP5000 imaging system (BIO-RAD, USA). The Quantity One was used to assess the band intensity and to carry out semi-quantitative analyses.

Measurement of Ca2+ Concentration

Rats (n=3 in each group) were intraperitoneally injected with 10% chloral hydrate (0.3g/kg) after the MWM tests, and the right hippocampi were rapidly separated. They were weighed and homogenized in an isotonic sucrose solution (0.32 mol/L) at 4°C in 1 g: 10 mL. The homogenate was centrifuged at 500g for 10 min to get the supernatant and then centrifuged at 4°C for 20 min (10000 g) to obtain the crude synaptosomal. The crude synaptosome was suspended with 0.32 mol/L sucrose solution, and then carefully spread over the density gradient of 0.8M and 1.2M sucrose. They were centrifuged with high-speed at 50000 g for 25 min to obtain the synaptosomes, and centrifuged at 2000 g for in 4°C to take precipitation [38]. The synaptosomes were quantified by BCA method and equal amounts (30 μg) of synaptosomes were added to each well of the black 96-well cell culture plate. Rhod 2-AM (1:500) probe 100 μL was added and incubated at 37°C for 30 min away from light. The culture medium was placed in a fluorescent microplate reader (BioTek FLx800, USA) to measure the fluorescence intensity at excitation wavelength of 557 nm and emission wavelength of 581 nm. Formula: [Ca2+]i=Kd(F-Fmin)/(Fmax-F).

Electrophysiology

After the MWM test, long-term potentiation was quantified with in vivo electrophysiological techniques. Rats (n=3in each group) were anaesthetized with an intraperitoneal injection of 20% urethane (1.2 g/kg), and then were positioned in a stereotaxic apparatus (Narishige, Japan) for surgery, covered with a towel to keep warm. A 3cm incision, blunt off the skin periosteum was cut to fully expose the bregma, sagittal suture, and parietal. A hole in the skull was drilled to expose CA3 region (4.2mm posterior to the bregma, 3.8mm right to the sagittal suture, 2.0 mm-3.5mm beneath the cortex) and CA1 region (3.4 mm posterior to the bregma, 2.5mm right to the sagittal suture, 1.5 mm-2.5mm beneath the cortex), coordinated according to the mouse brain atlas [35]. A bipolar stimulation electrode was placed in the CA3 region and a monopolar stainless steel recording electrode in the CA1 region. Stimulus-response was tested using a range of stimulation intensities from 0.1mA to 1 mA with 0.2ms,0.03HZ to determine the appropriate stimulating. The stimulating intensity (range 0.3-0.5 mA, stimulus pulse with 0.2 ms, at 0.03 Hz) that could evoke a response of 70% of its maximum amplitude was chosen for the following experiment. The basal field excitatory postsynaptic potentials (fEPSP) were recorded for 20 min with a single pulse of 2 times every minute. LTP was evoked by theta burst stimulation (TBS): 10 trains at 5 Hz consisting of 10 single pulses at 100 Hz. The f-EPSP was recorded for 60 min with a single pulse of 1 time every minute. LTP analysis was carried out in ClampFit (Molecular Devices, USA) and figures were constructed in KaleidaGraph (Synergy Sofware, Reading, PA, USA) using values for the amplitude of the fEPSP.

Statistical Analysis

Statistical analysis was performed with the Statistical Package for the Social Sciences (SPSS) v19.0, and all data were presented as Mean±SD. For the repeated measurement data (speed and escape latency time), repeated measurement analysis of variance (ANOVA) was applied to speed, and taking the sample size and normality, Generalized Estimating Equations analysis was applied to escape latency time; for other results, one way analysis of variance was applied with post-hoc LSD to data according to normality and homogeneity variance; or nonparametric test with Kruskal-Wallis was applied. The threshold for significance was set at P<0.05 for all analyses.

Results

OA Improves Spatial Learning and Memory Performance in the MWM Test

Swimming paths of rats in each group in the MWM test are presented in Fig. (. Repeated measurement ANOVA results showed that there was no significant difference in the average swimming speed in each group(F=0.331, P=0.721>0.05) (Fig. ).
Fig. (1)

Results of Morris water maze test(n=15). (A) Swimming paths of rats in each group in the Morris water maze. (B) Average swimming speed of rats in each group. Repeated measurement ANOVA results showed that there was no significant difference of the average swimming speed in each group(F=0.331, P = 0.721>0.05) (C) Escape latency time of rats in each group. Post Pairwise Comparisons using Bonferroni method showed that the latency time in model group was significantly longer than that in sham operation group (P=0.0001<0.05); while it was significantly shorter in the OA group than that in model group (P=0.0001<0.05) (D) platform crossing times of rats in each group. Post comparison with LSD method showed that compared with sham group, the times of cross-platform in model group significantly decreased (P = 0.007 <0.05); while compared with model group, the times of cross-platform in OA group significantly increased (P = 0.0001 <0.05).

Notes:*indicates compared with that in the sham operation group, P<0.05.

#indicates compared with that in the model group, P<0.05.

Escape Latency

In the MWM test, the escape latency was gradually shortened during the training period. Based on the Generalized Estimating Equations analysis, there was significant difference among three groups (P = 0.002<0.05), but no interaction between groups and time (P = 0.063> 0.05) (Table ). Based on the Estimated Marginal Means, the escape latency showed sham operation group < OA group < model group (Table ). Post Pairwise Comparisons using Bonferroni method showed that the latency time in model group was significantly longer than that in sham operation group (P=0.0001<0.05); while it was significantly shorter in the OA group than that in model group (P=0.0001<0.05).

Spatial Probe Test

One-way ANOVA analysis showed that there was a statistically significant difference among three groups (F = 9.056, P = 0.001 <0.05). Post comparison with LSD method showed that compared with sham group, the times of cross-platform in model group significantly decreased (P = 0.007 <0.05); while compared with model group, the times of cross-platform in OA group significantly increased (P = 0.0001 <0.05) (Fig. ).

OA Alleviates Neuron Damage and Synapses Changes Induced by Aβ25-35

TEM revealed that in the sham operation group, the neurons were intact, with homogeneous nuclei, abundant organelles, oval and full mitochondria, clear and intact double layer structure of the cristal membrane, endoplasmic reticulum attached with a large number of ribosomes. The synapses were normal with abundant synaptic vesicles secreted by presynaptic elements. The synaptic cleft was narrow, and the postsynaptic density was centralized (Fig. ). In the model group, neurons were not intact, with shrinking nuclei, severe disruption of organelles, rarely normal mitochondria in vacuolar state, ruptured endoplasmic reticulum with obvious loss of ribose. The abundance of synaptic vesicles secreted by presynaptic elements decreased. The synaptic cleft clearly widened, with sparse postsynaptic density (Fig. ). In the OA group, structures of neurons were intact on the whole, with homogeneous nuclei, abundant organelles, slightly swollen mitochondria, partial fusion and fracture of cristal membrane, slight loss of ribose of endoplasmic reticulum. Abundant synaptic vesicles secreted by presynaptic elements could be observed. The synaptic cleft was clear, without obvious widening, and the postsynaptic density was centralized (Fig. ).

OA could Improve the Expression of CaMKII, PKC, NMDAR2B, BDNF, TrkB, and CREB Protein

We measured protein levels of CaMKII, PKC, NMDAR2B, BDNF, TrkB, and CREB of the three groups. One way ANOVA results showed that there existed inter-group difference (CaMKII, F=1054.102, P=0.0001<0.05; PKC, F=5.346, P=0.046<0.05; NMDAR2B, F=16.949, P=0.003<0.05; BDNF, F=95.467, P=0.0001<0.05; TrkB, F=40049.417, P=0.0001<0.05, CREB, F=196.703, P=0.0001 <0.05). Post hoc statistics using LSD showed that compared with that in the sham operation group, the expression of CaMKII (Fig. ), PKC (Fig. , NMDAR2B (Fig. ), BDNF (Fig. ), TrkB (Fig. ), and CREB (Fig. ) were significantly lower in the model group, with statistically significant difference (P=0.0001, 0.026, 0.001, 0.0001, 0.0001, 0.0001, respectively). While compared with that in the model group, the expression of CaMKII (Fig. ), PKC (Fig. ), NMDAR2B (Fig. ), BDNF (Fig. ), TrkB (Fig. ), and CREB (Fig. ) were significantly higher in the OA group, with statistically significant difference (P=0.0001, 0.036, 0.041, 0.0001, 0.0001, 0.026, respectively). The levels of NR2B, Trkb, and CREB in OA group were still significantly lower than that in sham group (P=0.018<0.05, P=0.000 <0.05, P=0.000<0.05, respectively). The levels of BDNF and PKC in OA group were lower than that in sham group, but the difference was not statistically significant (P=0.165> 0.05, P=0.808>0.05, respectively). The level of CAMKII in OA group was higher than sham group, with significant difference (P=0.000<0.05).

OA Could Decrease the Concentration of Ca2+

Kruskal-Wallis test showed that compared with that in the sham operation group, the concentration of Ca2+ was significantly higher in the model group, with statistically significant difference (P=0.0001). While compared with that in the model group, the concentration of Ca2+ was significantly lower in the OA group, with statistically significant difference (P=0.015) (Table ).

OA Could Increase the Slope and Amplitude of 
f-EPSP

In the LTP assay, the stimulation electrode (SE) was placed in the CA3 region and the recording electrode (RE) in the CA1 region (Fig. ). Following the TBS stimulation (Fig. ), the fEPSPs slopes were recorded. Kruskal-Wallis test showed that the slope rate significantly decreased after high frequency stimulation in the model group compared with that in the sham operation group (P=0.0001). While compared with model group, the slope rate significantly increased after high frequency stimulation in the OA group (P=0.0001) (Fig. ). Kruskal-Wallis test showed that the amplitude significantly decreased after high frequency stimulation in the model group compared with that in the sham operation group (P=0.0001). While compared with model group, the amplitude significantly increased after high frequency stimulation in the OA group (P=0.0001) (Fig. ).

Discussion

AD is the most common form of dementia in the elderly, and it is characterized clinically by progressive cognitive impairment, memory loss, and altered behavior [39-41]. Several hypotheses have been proposed, and it is widely accepted that Aβ plays a central role [42, 43]. In our study, we build the AD model by injecting Aβ25-35 aggregate into right ventricle, which is a widely used model to study AD [44, 45]. It has been reported that Aβ injection would cause memory impairment [46, 47], and the results in our study that the escape latency increased and the frequency of platform crossing decreased in MWM test of rats in model group also proved that. While the lower escape latency and higher frequency of platform crossing in OA group represent that OA could ameliorate Aβ-induced spatial learning and memory loss of AD rats. It is widely accepted that the synapses play an important role in the formation of memory [48-50]. In the nervous system, synapses are esseential to neuronal functions:a synapse is a structure where a neuron could pass an electrical or chemical signal to another neuron. Evidences show that synapse loss or synaptic dysfunction is strongly correlated with memory impairment in AD, suggesting a causal role for dwindling synaptic integrity in the etiology of AD [51, 52]. Synapse is formed by presynaptic axon ending and by postsynaptic dendritic spine, and a similar loss of both pre-synaptic and post-synaptic components [53] as well as significant decreases in synaptic density of the hippocampus could occur in AD brains [54-56]. Synapse loss, suppressed presynaptic vesicle release [57, 58], and changes in the shape and size of dendritic spines [59] caused by Aβ deposition are the pathological hallmarks of AD, which was also found in our rats of model group by TEM. Our research showed that OA exhibited a positive effect on preserving neuron injury, improving the arrangements and the ultrastructure of neurons, and maintaining synaptic integrity, which suggested a protection and improvement of memory of AD rats. Change in pre-synaptic and post-synaptic components by a high local concentration of Aβ oligomers could affect neuronal Ca2+ homeostasis [60], which is a popular hypothesis of AD in recent years [61, 62]. The imbalance of Ca2+ homeostasis leading to extracellular Ca2+ flow into the cytoplasm, could cause Ca2+ overload. A persistent elevation of Ca2+ concentration could not only constantly disrupt memories but also contribute to neuronal cell death. Furthermore, it actually occurs prior to cognitive decline and extensive neuronal death in AD [63]. In our study, the injection of Aβ25-35 led to synaptic Ca2+ overload in model group, then causing neurotoxicity; while OA could effectively reduce synaptic Ca2+ concentration, and exhibited the role of neuroprotection to improve learning and memory deficit. Meanwhile, both pre-synaptic and post-synaptic mechanisms can contribute to the expression of synaptic plasticity, one of the important neurochemical foundations of learning and memory [64, 65]. Presynaptic vesicle could release neurotransmitters which are directly proportional to synaptic transmission strength. There are a lot of proteins such as 
N-methyl-Daspartate receptor (NMDARs), calmodulin-dependent-protein kinase II (CaMKII), and protein kinase C (PKC) in postsynaptic density (PSD), and the destruction of PSD could inactivate synaptic proteins, influence synaptic homeostasis, leading to negative synaptic formation and synaptic loss and dysfunction in AD [66, 67]. NMDAR, CaMKII, and PKC in PSD play essential roles in synaptic plasticity. The accumulated evidences demonstrated NMDAR was dysfunctional, and the protein activation of CaMKII and PKC was suppressed in AD. In our study, NMDAR2B, CaMKII and PKC protein expression, all significantly decreased in model group. We also found that OA could increase the NMDAR2B, CaMKII and PKC protein expression, to restore and maintain synaptic plasticity. Long-term potentiation (LTP), a main form of long-term synaptic plasticity, is an increase in synaptic response following potentiating pulses of electrical stimuli, and the induction and maintenance of it could reflect the strength of synaptic transmission efficiency, which was widely considered as one of the major cellular mechanisms underlying learning and memory [68-70]. It has been reported that LTP of hippocampal CA1 area was significantly inhibited in Aβ25-35 induced learning-and-memory-impairment rats [71]. Moreover, when the way to form LTP was blocked, learning and memory would be inhibited, suggesting that the cognitive decline in individuals with AD might result from impaired LTP [72, 73]. In our study, the slope and amplitude of fEPSP were taken as reference values for LTP (fEPSP to reflect the amount of excitatory synapse, slope to reflect the speed of synaptic response to stimuli, and amplitude to the intensity of synaptic stimulation). Before TBS, the amplitude and slope of fEPSP in the model group and sham operation group were consistent; while after TBS, the amplitude and slope of fEPSP in the model group were significantly lower than those in the sham operation group, suggesting that Aβ25-35 does not affect the basic function of synaptic transmission, but it inhibits TBS induced LTP. Our results also showed that OA could increase the amplitude and slope of fEPSP in AD models, indicating it could enhance the synaptic transmission. In the maintenance and induction of LTP, brain-derived neurotrophic factor (BDNF), as a major regulator of synaptic structure and function, through tyrosine kinase B (TrkB) plays an essential role [74, 75], and reduced BDNF/TrkB leads to impaired spatial memory in AD. The increased BDNF/TrkB expression could activate Cyclic AMP response element binding protein (CREB), a constitutively expressed nuclear transcription factor that regulates the expression of genes involved in cognition and neuronal survival [76]. CREB shows a well-documented role in the formation and retention of memory by mediating gene expression in the hippocampus during LTP [77, 78]. CREB down-regulation is implicated in AD and increasing the expression of CREB is being considered as a possible therapeutic target for AD [79]. In our study, the expression of BDNF, TrkB, CREB proteins were all significantly suppressed in model group, while OA showed an up-regulating effect on them to enhance LTP.

Conclusion

In conclusions, we found that OA could ameliorate Aβ-induced memory loss of AD rats, which has never been reported before. And during the treatment, OA showed a protective effect in maintaining synaptic integrity to restore synaptic plasticity by increasing the NMDAR2B, CaMKII and PKC protein expression in PSD, reducing synaptic Ca2+ concentration, enhancing the inhibited LTP after Aβ25-35 injection by up-regulating the expression of BDNF, TrkB, CREB proteins, which might be its mechanism in improving learning and memory deficit.
Table 1

Tests model effects.

- Wald Chi-square Value Variance Sig.
(Intercept)333.31710.0001
Groups12.82720.002
Time190.29810.0001
Groups×Times5.52320.063
Table 2

Estimated marginal means of escape latency.

Groups Mean Standard Error 95% Wald Confidence Interval
Lower Upper
Sham13.952.039.9717.94
Model24.642.1120.5128.78
OA16.892.2912.4021.37
Table 3

Ca2+ concentration of each group (Mean±SD).

Group n Rhod-2 Fluorescence
Sham operation30.96±0.09
Model31.68±0.18*
OA31.11±0.42#

Notes: *indicates compared with that in the sham operation group, P<0.05.

#indicates compared with that in the model group, P<0.05

  78 in total

1.  Abeta(25-35) and Abeta(1-40) act on different calcium channels in CA1 hippocampal neurons.

Authors:  Catherine Rovira; Nicolas Arbez; Jean Mariani
Journal:  Biochem Biophys Res Commun       Date:  2002-09-06       Impact factor: 3.575

2.  The isolation of nerve endings from brain: an electron-microscopic study of cell fragments derived by homogenization and centrifugation.

Authors:  E G GRAY; V P WHITTAKER
Journal:  J Anat       Date:  1962-01       Impact factor: 2.610

3.  Gami-Chunghyuldan ameliorates memory impairment and neurodegeneration induced by intrahippocampal Aβ 1-42 oligomer injection.

Authors:  Jin Gyu Choi; Minho Moon; Hyo Geun Kim; Inhee Mook-Jung; Sun Yong Chung; Tong Ho Kang; Sun Yeou Kim; Eunjoo H Lee; Myung Sook Oh
Journal:  Neurobiol Learn Mem       Date:  2011-06-13       Impact factor: 2.877

4.  Impact of interventions to reduce Alzheimer's disease pathology on the prevalence of dementia in the oldest-old.

Authors:  Ron Brookmeyer; Claudia H Kawas; Nada Abdallah; Annlia Paganini-Hill; Ronald C Kim; María M Corrada
Journal:  Alzheimers Dement       Date:  2016-02-17       Impact factor: 21.566

5.  Inhibitory effect of ethanol extract of Magnolia officinalis on memory impairment and amyloidogenesis in a transgenic mouse model of Alzheimer's disease via regulating β-secretase activity.

Authors:  Young-Jung Lee; Dong-Young Choi; Sang Bae Han; Young Hee Kim; Ki Ho Kim; Bang Yeon Hwang; Jong-Koo Kang; Beom Jun Lee; Ki-Won Oh; Jin Tae Hong
Journal:  Phytother Res       Date:  2012-03-19       Impact factor: 5.878

6.  Effect of a CYP2D6 polymorphism on the efficacy of donepezil in patients with Alzheimer disease.

Authors:  Alberto Pilotto; M Franceschi; G D'Onofrio; A Bizzarro; F Mangialasche; L Cascavilla; F Paris; M G Matera; Andrea Pilotto; A Daniele; P Mecocci; C Masullo; B Dallapiccola; D Seripa
Journal:  Neurology       Date:  2009-09-08       Impact factor: 9.910

7.  Calcium signaling and neurodegenerative diseases.

Authors:  Ilya Bezprozvanny
Journal:  Trends Mol Med       Date:  2009-02-21       Impact factor: 11.951

8.  Sodium phenylbutyrate enhances astrocytic neurotrophin synthesis via protein kinase C (PKC)-mediated activation of cAMP-response element-binding protein (CREB): implications for Alzheimer disease therapy.

Authors:  Grant T Corbett; Avik Roy; Kalipada Pahan
Journal:  J Biol Chem       Date:  2013-02-12       Impact factor: 5.157

9.  HCV protease inhibitory, cytotoxic and apoptosis-inducing effects of oleanolic acid derivatives.

Authors:  Chao-Mei Ma; Xiu-Hong Wu; Hattori Masao; Xi-Jun Wang; Yoshihiro Kano
Journal:  J Pharm Pharm Sci       Date:  2009       Impact factor: 2.327

10.  Extrasynaptic NMDA receptor dependent long-term potentiation of hippocampal CA1 pyramidal neurons.

Authors:  Qian Yang; Geng Zhu; Dandan Liu; Jue-Gang Ju; Zhen-Hua Liao; Yi-Xin Xiao; Yue Zhang; Naijian Chao; JieJie Wang; Weidong Li; Jian-Hong Luo; Sheng-Tian Li
Journal:  Sci Rep       Date:  2017-06-08       Impact factor: 4.379

View more
  16 in total

1.  Angelica polysaccharide ameliorates memory impairment in Alzheimer's disease rat through activating BDNF/TrkB/CREB pathway.

Authors:  Qian Du; Xiaoyu Zhu; Jieru Si
Journal:  Exp Biol Med (Maywood)       Date:  2019-12-17

2.  Ursolic acid and its isomer oleanolic acid are responsible for the anti-dementia effects of Ocimum sanctum in olfactory bulbectomized mice.

Authors:  Hien Thu Nguyen; Xoan Thi Le; Tai Van Nguyen; Hoa Nhu Phung; Hang Thi Nguyet Pham; Khoi Minh Nguyen; Kinzo Matsumoto
Journal:  J Nat Med       Date:  2022-02-26       Impact factor: 2.343

Review 3.  Recent Advances Regarding the Molecular Mechanisms of Triterpenic Acids: A Review (Part I).

Authors:  Marius Mioc; Andreea Milan; Daniel Malița; Alexandra Mioc; Alexandra Prodea; Roxana Racoviceanu; Roxana Ghiulai; Andreea Cristea; Florina Căruntu; Codruța Șoica
Journal:  Int J Mol Sci       Date:  2022-07-13       Impact factor: 6.208

4.  Ocimum sanctum Linn. Extract Improves Cognitive Deficits in Olfactory Bulbectomized Mice via the Enhancement of Central Cholinergic Systems and VEGF Expression.

Authors:  Xoan Thi Le; Hien Thu Nguyen; Tai Van Nguyen; Hang Thi Nguyet Pham; Phuong Thi Nguyen; Khoi Minh Nguyen; Ba Van Nguyen; Kinzo Matsumoto
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-30       Impact factor: 2.629

5.  Impaired Learning and Memory Ability Induced by a Bilaterally Hippocampal Injection of Streptozotocin in Mice: Involved With the Adaptive Changes of Synaptic Plasticity.

Authors:  Cong-Cong Qi; Xing-Xing Chen; Xin-Ran Gao; Jing-Xian Xu; Sen Liu; Jin-Fang Ge
Journal:  Front Aging Neurosci       Date:  2021-03-01       Impact factor: 5.750

6.  Astaxanthin alleviates pathological brain aging through the upregulation of hippocampal synaptic proteins.

Authors:  Ning Liu; Liang Zeng; Yi-Ming Zhang; Wang Pan; Hong Lai
Journal:  Neural Regen Res       Date:  2021-06       Impact factor: 5.135

7.  Uncovering the active compounds and effective mechanisms of the dried mature sarcocarp of Cornus officinalis Sieb. Et Zucc. For the treatment of Alzheimer's disease through a network pharmacology approach.

Authors:  Yan-Jie Qu; Rong-Rong Zhen; Li-Min Zhang; Chao Gu; Lei Chen; Xiao Peng; Bing Hu; Hong-Mei An
Journal:  BMC Complement Med Ther       Date:  2020-05-25

Review 8.  Potential Herb-Drug Interactions in the Management of Age-Related Cognitive Dysfunction.

Authors:  Maria D Auxtero; Susana Chalante; Mário R Abade; Rui Jorge; Ana I Fernandes
Journal:  Pharmaceutics       Date:  2021-01-19       Impact factor: 6.321

9.  MiR-485-3p serves as a biomarker and therapeutic target of Alzheimer's disease via regulating neuronal cell viability and neuroinflammation by targeting AKT3.

Authors:  Ling Yu; Haiting Li; Wenhu Liu; Ligong Zhang; Qun Tian; Hairong Li; Min Li
Journal:  Mol Genet Genomic Med       Date:  2020-11-21       Impact factor: 2.183

10.  Brain-Derived Neurotrophic Factor (BDNF) Preserves the Functional Integrity of Neural Networks in the β-Amyloidopathy Model in vitro.

Authors:  Elena V Mitroshina; Roman S Yarkov; Tatiana A Mishchenko; Victoria G Krut'; Maria S Gavrish; Ekaterina A Epifanova; Alexey A Babaev; Maria V Vedunova
Journal:  Front Cell Dev Biol       Date:  2020-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.